87 related articles for article (PubMed ID: 14977050)
1. Monitoring human parvovirus B19 virus-like particles and antibody complexes in solution by fluorescence correlation spectroscopy.
Toivola J; Michel PO; Gilbert L; Lahtinen T; Marjomäki V; Hedman K; Vuento M; Oker-Blom C
Biol Chem; 2004 Jan; 385(1):87-93. PubMed ID: 14977050
[TBL] [Abstract][Full Text] [Related]
2. Molecular and structural characterization of fluorescent human parvovirus B19 virus-like particles.
Gilbert L; Toivola J; White D; Ihalainen T; Smith W; Lindholm L; Vuento M; Oker-Blom C
Biochem Biophys Res Commun; 2005 Jun; 331(2):527-35. PubMed ID: 15850791
[TBL] [Abstract][Full Text] [Related]
3. Disassembly of structurally modified viral nanoparticles: characterization by fluorescence correlation spectroscopy.
Toivola J; Gilbert L; Michel P; White D; Vuento M; Oker-Blom C
C R Biol; 2005 Dec; 328(12):1052-6. PubMed ID: 16314283
[TBL] [Abstract][Full Text] [Related]
4. Recombinant viral-like particles of parvovirus B19 as antigen carriers of anthrax protective antigen.
Ogasawara Y; Amexis G; Yamaguchi H; Kajigaya S; Leppla SH; Young NS
In Vivo; 2006; 20(3):319-24. PubMed ID: 16724664
[TBL] [Abstract][Full Text] [Related]
5. Measurement of lateral transport on cell surfaces.
Elson EL; Schlessinger J; Koppel DE; Axelrod D; Webb WW
Prog Clin Biol Res; 1976; 9():137-47. PubMed ID: 1030797
[TBL] [Abstract][Full Text] [Related]
6. Microenvironment of endosomal aqueous phase investigated by the mobility of microparticles using fluorescence correlation spectroscopy.
Yoshida N; Kinjo M; Tamura M
Biochem Biophys Res Commun; 2001 Jan; 280(1):312-8. PubMed ID: 11162516
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections.
Holmes DA; Purdy DE; Chao DY; Noga AJ; Chang GJ
J Clin Microbiol; 2005 Jul; 43(7):3227-36. PubMed ID: 16000440
[TBL] [Abstract][Full Text] [Related]
8. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
Pfrepper KI; Enders M; Motz M
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):362-5. PubMed ID: 16316402
[TBL] [Abstract][Full Text] [Related]
9. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ
J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987
[TBL] [Abstract][Full Text] [Related]
10. Size dependence of protein diffusion very close to membrane surfaces: measurement by total internal reflection with fluorescence correlation spectroscopy.
Pero JK; Haas EM; Thompson NL
J Phys Chem B; 2006 Jun; 110(22):10910-8. PubMed ID: 16771344
[TBL] [Abstract][Full Text] [Related]
11. Detection of IgE anti-parvovirus antibodies in human breast milk.
Smith-Norowitz TA; Drew H; Norowitz HM; Nowakowski M; Bluth EF; Durkin HG; Bluth MH
Ann Clin Lab Sci; 2008; 38(2):168-73. PubMed ID: 18469364
[TBL] [Abstract][Full Text] [Related]
12. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
Enders M; Schalasta G; Baisch C; Weidner A; Pukkila L; Kaikkonen L; Lankinen H; Hedman L; Söderlund-Venermo M; Hedman K
J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
[TBL] [Abstract][Full Text] [Related]
13. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
[TBL] [Abstract][Full Text] [Related]
14. The immune response to parvovirus B19 exposure in previously seronegative and seropositive individuals.
Doyle S; Corcoran A
J Infect Dis; 2006 Jul; 194(2):154-8. PubMed ID: 16779720
[TBL] [Abstract][Full Text] [Related]
15. Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops.
Enders M; Weidner A; Rosenthal T; Baisch C; Hedman L; Söderlund-Venermo M; Hedman K
J Infect Dis; 2008 Jan; 197(1):58-62. PubMed ID: 18171285
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of two commercial enzyme immunoassays for serodiagnosis of human parvovirus B19 infection.
Enders M; Helbig S; Hunjet A; Pfister H; Reichhuber C; Motz M
J Virol Methods; 2007 Dec; 146(1-2):409-13. PubMed ID: 17854916
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province].
Wei Q; Li Y; Wang JW; Wang H; Qu JG; Hung T
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):60-2. PubMed ID: 16816866
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections.
Braham S; Gandhi J; Beard S; Cohen B
J Clin Virol; 2004 Sep; 31(1):5-10. PubMed ID: 15288606
[TBL] [Abstract][Full Text] [Related]
19. Antibody-mediated opsonization of red blood cells in parvovirus B19 infection.
Chehadeh W; Halim MA; Al-Nakib W
Virology; 2009 Jul; 390(1):56-63. PubMed ID: 19450862
[TBL] [Abstract][Full Text] [Related]
20. Properties of baculovirus particles displaying GFP analyzed by fluorescence correlation spectroscopy.
Toivola J; Ojala K; Michel PO; Vuento M; Oker-Blom C
Biol Chem; 2002 Dec; 383(12):1941-6. PubMed ID: 12553731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
